Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-584735
Filing Date
2016-05-10
Accepted
2016-05-10 07:49:33
Documents
47
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d166602d10q.htm 10-Q 226139
2 EX-10.1 d166602dex101.htm EX-10.1 87734
3 EX-31.1 d166602dex311.htm EX-31.1 8945
4 EX-31.2 d166602dex312.htm EX-31.2 8935
5 EX-32.1 d166602dex321.htm EX-32.1 4377
6 EX-32.2 d166602dex322.htm EX-32.2 4378
  Complete submission text file 0001193125-16-584735.txt   1887625

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT galt-20160331.xml EX-101.INS 204665
8 XBRL TAXONOMY EXTENSION SCHEMA galt-20160331.xsd EX-101.SCH 27857
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20160331_cal.xml EX-101.CAL 29724
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20160331_def.xml EX-101.DEF 165365
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20160331_lab.xml EX-101.LAB 226644
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20160331_pre.xml EX-101.PRE 195799
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 161633725
SIC: 2834 Pharmaceutical Preparations